Company Profile

CEL-SCI Corp

Name: Global Corporate Sustainability Reports Database
Creator: SustainabilityReports.com
License: https://creativecommons.org/licenses/by/4.0/

CEL-SCI Corp. is a biotechnology company focused on researching and developing immunotherapy products for the treatment of cancer and infectious diseases. Its lead investigational candidate is Multikine, which is being studied for the treatment of head and neck cancer.

MIC

Ticker

ISIN

Website

cel-sci.com

Country

United States

Exchange

NYSE American

Sector

Manufacturing

Industry

Pharmaceuticals

Reports

CEL-SCI Corp

Available reports

CEL-SCI Corp

Available reports